Showing results (171-180 of 199) with videos related to
Sort By:
Pageof 20
Iscience|June 11, 2020
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder CancerGuoliang Yang, Jolanta Bondaruk, David Cogdell, et al.JAMA Network Open|August 30, 2021
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint InhibitorsPavlos Msaouel, Clara Oromendia, Arlene O Siefker-Radtke, et al.Biomarker Research|November 10, 2024
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillanceJustin R Gregg, Lisa Newcomb, Ranran Wu, et al.Frontiers in Public Health|February 23, 2023
Efficacy of a comprehensive strategy for the detection and treatment of hepatitis C infection in a population attending addiction centersDiana Corona-Mata, Antonio Rivero-Juárez, Ángela Camacho, et al.Frontiers in Public Health|January 31, 2024
Comparison of hepatitis B and SARS-CoV2 vaccination rates in people who attended Drugs and Addiction CentresDiana Corona-Mata, Antonio Rivero-Juárez, Ángela Camacho, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working GroupHoward I Scher, Mario Eisenberger, Anthony V D'Amico, et al.European Urology Oncology|October 13, 2023
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary TractOmar Alhalabi, Nathaniel Wilson, Lianchun Xiao, et al.European Urology|August 20, 2020
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term SurvivorsKarim Fizazi, Charles G Drake, Tomasz M Beer, et al.Cancer|November 20, 2019
Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trendsChad Tang, Karen E Hoffman, Pamela K Allen, et al.Prostate Cancer and Prostatic Diseases|July 17, 2024
Body composition as a determinant of the therapeutic index with androgen signaling inhibitionAndrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, et al.Pageof 20